Global Intrauterine Contraceptive Market Insights, Forecast to 2025
- QYR2792361
- 118 Pages
- October 2018
- Medical Devices
Increasing prevalence of unplanned pregnancies, less side-effects associated with intrauterine contraceptive devices, and implementation of affordable care are some of the key factors driving the growth of the global intrauterine contraceptive device market. In addition, increasing awareness about pregnancy is also driving the growth of the global intrauterine contraceptive device market.
The global Intrauterine Contraceptive market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Intrauterine Contraceptive market based on company, product type, end user and key regions.
This report studies the global market size of Intrauterine Contraceptive in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intrauterine Contraceptive in these regions.
This research report categorizes the global Intrauterine Contraceptive market by top players/brands, region, type and end user. This report also studies the global Intrauterine Contraceptive market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva Pharmaceutical Industries
Medicines360
Trimedic Supply Network
Bayer Healthcare
Actavis
Medisafe Distribution
Pace Pharmaceuticals
Market size by Product
Hormonal IUCD
Copper IUCD
Market size by End User
Hospitals
Gynecological Clinics
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Intrauterine Contraceptive market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Intrauterine Contraceptive market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intrauterine Contraceptive companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intrauterine Contraceptive submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Intrauterine Contraceptive are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intrauterine Contraceptive market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Intrauterine Contraceptive Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intrauterine Contraceptive Market Size Growth Rate by Product
1.4.2 Hormonal IUCD
1.4.3 Copper IUCD
1.5 Market by End User
1.5.1 Global Intrauterine Contraceptive Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Gynecological Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intrauterine Contraceptive Market Size
2.1.1 Global Intrauterine Contraceptive Revenue 2013-2025
2.1.2 Global Intrauterine Contraceptive Sales 2013-2025
2.2 Intrauterine Contraceptive Growth Rate by Regions
2.2.1 Global Intrauterine Contraceptive Sales by Regions
2.2.2 Global Intrauterine Contraceptive Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Intrauterine Contraceptive Sales by Manufacturers
3.1.1 Intrauterine Contraceptive Sales by Manufacturers
3.1.2 Intrauterine Contraceptive Sales Market Share by Manufacturers
3.1.3 Global Intrauterine Contraceptive Market Concentration Ratio (CR5 and HHI)
3.2 Intrauterine Contraceptive Revenue by Manufacturers
3.2.1 Intrauterine Contraceptive Revenue by Manufacturers (2013-2018)
3.2.2 Intrauterine Contraceptive Revenue Share by Manufacturers (2013-2018)
3.3 Intrauterine Contraceptive Price by Manufacturers
3.4 Intrauterine Contraceptive Manufacturing Base Distribution, Product Types
3.4.1 Intrauterine Contraceptive Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intrauterine Contraceptive Product Type
3.4.3 Date of International Manufacturers Enter into Intrauterine Contraceptive Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Intrauterine Contraceptive Sales by Product
4.2 Global Intrauterine Contraceptive Revenue by Product
4.3 Intrauterine Contraceptive Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Intrauterine Contraceptive Breakdown Data by End User
6 North America
6.1 North America Intrauterine Contraceptive by Countries
6.1.1 North America Intrauterine Contraceptive Sales by Countries
6.1.2 North America Intrauterine Contraceptive Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Intrauterine Contraceptive by Product
6.3 North America Intrauterine Contraceptive by End User
7 Europe
7.1 Europe Intrauterine Contraceptive by Countries
7.1.1 Europe Intrauterine Contraceptive Sales by Countries
7.1.2 Europe Intrauterine Contraceptive Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intrauterine Contraceptive by Product
7.3 Europe Intrauterine Contraceptive by End User
8 Asia Pacific
8.1 Asia Pacific Intrauterine Contraceptive by Countries
8.1.1 Asia Pacific Intrauterine Contraceptive Sales by Countries
8.1.2 Asia Pacific Intrauterine Contraceptive Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Intrauterine Contraceptive by Product
8.3 Asia Pacific Intrauterine Contraceptive by End User
9 Central & South America
9.1 Central & South America Intrauterine Contraceptive by Countries
9.1.1 Central & South America Intrauterine Contraceptive Sales by Countries
9.1.2 Central & South America Intrauterine Contraceptive Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Intrauterine Contraceptive by Product
9.3 Central & South America Intrauterine Contraceptive by End User
10 Middle East and Africa
10.1 Middle East and Africa Intrauterine Contraceptive by Countries
10.1.1 Middle East and Africa Intrauterine Contraceptive Sales by Countries
10.1.2 Middle East and Africa Intrauterine Contraceptive Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Intrauterine Contraceptive by Product
10.3 Middle East and Africa Intrauterine Contraceptive by End User
11 Company Profiles
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Company Details
11.1.2 Company Business Overview
11.1.3 Teva Pharmaceutical Industries Intrauterine Contraceptive Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Teva Pharmaceutical Industries Intrauterine Contraceptive Products Offered
11.1.5 Teva Pharmaceutical Industries Recent Development
11.2 Medicines360
11.2.1 Medicines360 Company Details
11.2.2 Company Business Overview
11.2.3 Medicines360 Intrauterine Contraceptive Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Medicines360 Intrauterine Contraceptive Products Offered
11.2.5 Medicines360 Recent Development
11.3 Trimedic Supply Network
11.3.1 Trimedic Supply Network Company Details
11.3.2 Company Business Overview
11.3.Trimedic Supply Network Intrauterine Contraceptive Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Trimedic Supply Network Intrauterine Contraceptive Products Offered
11.3.5 Trimedic Supply Network Recent Development
11.4 Bayer Healthcare
11.4.1 Bayer Healthcare Company Details
11.4.2 Company Business Overview
11.4.3 Bayer Healthcare Intrauterine Contraceptive Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Bayer Healthcare Intrauterine Contraceptive Products Offered
11.4.5 Bayer Healthcare Recent Development
11.5 Actavis
11.5.1 Actavis Company Details
11.5.2 Company Business Overview
11.5.3 Actavis Intrauterine Contraceptive Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Actavis Intrauterine Contraceptive Products Offered
11.5.5 Actavis Recent Development
11.6 Medisafe Distribution
11.6.1 Medisafe Distribution Company Details
11.6.2 Company Business Overview
11.6.3 Medisafe Distribution Intrauterine Contraceptive Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Medisafe Distribution Intrauterine Contraceptive Products Offered
11.6.5 Medisafe Distribution Recent Development
11.7 Pace Pharmaceuticals
11.7.1 Pace Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Pace Pharmaceuticals Intrauterine Contraceptive Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Pace Pharmaceuticals Intrauterine Contraceptive Products Offered
11.7.5 Pace Pharmaceuticals Recent Development
12 Future Forecast
12.1 Intrauterine Contraceptive Market Forecast by Regions
12.1.1 Global Intrauterine Contraceptive Sales Forecast by Regions 2018-2025
12.1.2 Global Intrauterine Contraceptive Revenue Forecast by Regions 2018-2025
12.2 Intrauterine Contraceptive Market Forecast by Product
12.2.1 Global Intrauterine Contraceptive Sales Forecast by Product 2018-2025
12.2.2 Global Intrauterine Contraceptive Revenue Forecast by Product 2018-2025
12.3 Intrauterine Contraceptive Market Forecast by End User
12.4 North America Intrauterine Contraceptive Forecast
12.5 Europe Intrauterine Contraceptive Forecast
12.6 Asia Pacific Intrauterine Contraceptive Forecast
12.7 Central & South America Intrauterine Contraceptive Forecast
12.8 Middle East and Africa Intrauterine Contraceptive Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intrauterine Contraceptive Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Intrauterine Contraceptive Product Picture
Table Intrauterine Contraceptive Market Segments
Table Key Manufacturers Intrauterine Contraceptive Covered
Table Global Intrauterine Contraceptive Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Intrauterine Contraceptive Sales Market Share by Product 2013-2025
Figure Hormonal IUCD Product Picture
Table Major Manufacturers of Hormonal IUCD
Figure Copper IUCD Product Picture
Table Major Manufacturers of Copper IUCD
Table Global Intrauterine Contraceptive Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Hospitals
Figure Gynecological Clinics
Figure Other
Figure Intrauterine Contraceptive Report Years Considered
Figure Global Intrauterine Contraceptive Market Size 2013-2025 (Million US$)
Figure Global Intrauterine Contraceptive Sales 2013-2025 (K Units)
Table Global Intrauterine Contraceptive Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Intrauterine Contraceptive Sales by Regions 2013-2018 (K Units)
Table Global Intrauterine Contraceptive Sales Market Share by Regions 2013-2018
Figure Global Intrauterine Contraceptive Sales Market Share by Regions 2013-2018
Figure 2017 Global Intrauterine Contraceptive Sales Market Share by Regions
Table Global Intrauterine Contraceptive Revenue by Regions 2013-2018 (Million US$)
Table Global Intrauterine Contraceptive Revenue Market Share by Regions 2013-2018
Figure Global Intrauterine Contraceptive Revenue Market Share by Regions 2013-2018
Figure 2017 Global Intrauterine Contraceptive Revenue Market Share by Regions
Table Global Intrauterine Contraceptive Sales by Manufacturers (2013-2018) (K Units)
Table Global Intrauterine Contraceptive Sales Share by Manufacturers (2013-2018)
Figure Global Intrauterine Contraceptive Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Intrauterine Contraceptive Revenue by Manufacturers (2013-2018) (Million USD)
Table Intrauterine Contraceptive Revenue Share by Manufacturers (2013-2018)
Figure Intrauterine Contraceptive Value Share by Manufacturers in 2017
Table Key Manufacturers Intrauterine Contraceptive Price (2013-2018) (USD/Unit)
Table Intrauterine Contraceptive Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Intrauterine Contraceptive Product Type
Table Date of International Manufacturers Enter into Intrauterine Contraceptive Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Intrauterine Contraceptive Sales by Product (2013-2018) (K Units)
Table Global Intrauterine Contraceptive Sales Share by Product (2013-2018)
Figure Global Intrauterine Contraceptive Sales Market Share by Product (2013-2018)
Figure Global Intrauterine Contraceptive Sales Market Share by Product in 2017
Table Global Intrauterine Contraceptive Revenue by Product (2013-2018) (Million US$)
Table Global Intrauterine Contraceptive Revenue Share by Product (2013-2018)
Figure Global Intrauterine Contraceptive Revenue Market Share by Product (2013-2018)
Figure Global Intrauterine Contraceptive Revenue Market Share by Product in 2017
Table Intrauterine Contraceptive Price by Product 2013-2018 (USD/Unit)
Table Global Intrauterine Contraceptive Sales by End User (2013-2018) (K Units)
Table Global Intrauterine Contraceptive Sales Share by End User (2013-2018)
Figure Global Sales Intrauterine Contraceptive Market Share by End User (2013-2018)
Figure Global Sales Intrauterine Contraceptive Market Share by End User in 2017
Figure North America Intrauterine Contraceptive Sales Growth Rate 2013-2018 (K Units)
Figure North America Intrauterine Contraceptive Revenue Growth Rate 2013-2018 (Million US$)
Table North America Intrauterine Contraceptive Sales by Countries (2013-2018) (K Units)
Table North America Intrauterine Contraceptive Sales Market Share by Countries (2013-2018)
Figure 2017 North America Intrauterine Contraceptive Sales Market Share by Countries
Table North America Intrauterine Contraceptive Revenue by Countries (2013-2018) (Million US$)
Table North America Intrauterine Contraceptive Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Intrauterine Contraceptive Revenue Market Share by Countries
Figure United States Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure United States Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Canada Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Table North America Intrauterine Contraceptive Sales by Product (2013-2018) (K Units)
Table North America Intrauterine Contraceptive Sales Market Share by Product (2013-2018)
Figure 2017 North America Intrauterine Contraceptive Market Share by Product
Table North America Intrauterine Contraceptive Sales by End User (2013-2018) (K Units)
Table North America Intrauterine Contraceptive Sales Market Share by End User (2013-2018)
Figure 2017 North America Intrauterine Contraceptive Market Share by End User
Figure Europe Intrauterine Contraceptive Sales Growth Rate 2013-2018 (K Units)
Figure Europe Intrauterine Contraceptive Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Intrauterine Contraceptive Sales by Countries (2013-2018) (K Units)
Table Europe Intrauterine Contraceptive Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Intrauterine Contraceptive Sales Market Share by Countries
Table Europe Intrauterine Contraceptive Revenue by Countries (2013-2018) (Million US$)
Table Europe Intrauterine Contraceptive Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Intrauterine Contraceptive Revenue Market Share by Countries
Figure Germany Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Germany Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure France Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure France Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure UK Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Italy Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Russia Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Intrauterine Contraceptive Sales by Product (2013-2018) (K Units)
Table Europe Intrauterine Contraceptive Sales Market Share by Product (2013-2018)
Figure 2017 Europe Intrauterine Contraceptive Market Share by Product
Table Europe Intrauterine Contraceptive Sales by End User (2013-2018) (K Units)
Table Europe Intrauterine Contraceptive Sales Market Share by End User (2013-2018)
Figure 2017 Europe Intrauterine Contraceptive Market Share by End User
Figure Asia Pacific Intrauterine Contraceptive Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Intrauterine Contraceptive Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Intrauterine Contraceptive Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Intrauterine Contraceptive Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Intrauterine Contraceptive Sales Market Share by Countries
Table Asia Pacific Intrauterine Contraceptive Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Intrauterine Contraceptive Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Intrauterine Contraceptive Revenue Market Share by Countries
Figure China Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure China Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Japan Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Korea Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure India Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure India Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Australia Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Intrauterine Contraceptive Sales by Product (2013-2018) (K Units)
Table Asia Pacific Intrauterine Contraceptive Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Intrauterine Contraceptive Market Share by Product
Table Asia Pacific Intrauterine Contraceptive Sales by End User (2013-2018) (K Units)
Table Asia Pacific Intrauterine Contraceptive Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Intrauterine Contraceptive Market Share by End User
Figure Central & South America Intrauterine Contraceptive Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Intrauterine Contraceptive Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Intrauterine Contraceptive Sales by Countries (2013-2018) (K Units)
Table Central & South America Intrauterine Contraceptive Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Intrauterine Contraceptive Sales Market Share by Countries
Table Central & South America Intrauterine Contraceptive Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Intrauterine Contraceptive Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Intrauterine Contraceptive Revenue Market Share by Countries
Figure Brazil Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Intrauterine Contraceptive Sales by Product (2013-2018) (K Units)
Table Central & South America Intrauterine Contraceptive Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Intrauterine Contraceptive Market Share by Product
Table Central & South America Intrauterine Contraceptive Sales by End User (2013-2018) (K Units)
Table Central & South America Intrauterine Contraceptive Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Intrauterine Contraceptive Market Share by End User
Figure Middle East and Africa Intrauterine Contraceptive Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Intrauterine Contraceptive Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Intrauterine Contraceptive Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Intrauterine Contraceptive Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Intrauterine Contraceptive Sales Market Share by Countries
Table Middle East and Africa Intrauterine Contraceptive Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Intrauterine Contraceptive Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Intrauterine Contraceptive Revenue Market Share by Countries
Figure GCC Countries Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Intrauterine Contraceptive Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Intrauterine Contraceptive Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Intrauterine Contraceptive Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Intrauterine Contraceptive Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Intrauterine Contraceptive Market Share by Product
Table Middle East and Africa Intrauterine Contraceptive Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Intrauterine Contraceptive Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Intrauterine Contraceptive Market Share by End User
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Intrauterine Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Teva Pharmaceutical Industries Recent Development
Table Medicines360 Company Details
Table Medicines360 Intrauterine Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Medicines360 Recent Development
Table Trimedic Supply Network Company Details
Table Trimedic Supply Network Intrauterine Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Trimedic Supply Network Recent Development
Table Bayer Healthcare Company Details
Table Bayer Healthcare Intrauterine Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer Healthcare Recent Development
Table Actavis Company Details
Table Actavis Intrauterine Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Actavis Recent Development
Table Medisafe Distribution Company Details
Table Medisafe Distribution Intrauterine Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Medisafe Distribution Recent Development
Table Pace Pharmaceuticals Company Details
Table Pace Pharmaceuticals Intrauterine Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pace Pharmaceuticals Recent Development
Table Global Intrauterine Contraceptive Sales Forecast by Regions 2018-2025 (K Units)
Table Global Intrauterine Contraceptive Sales Market Share Forecast by Regions 2018-2025
Table Global Intrauterine Contraceptive Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Intrauterine Contraceptive Revenue Market Share Forecast by Regions 2018-2025
Table Global Intrauterine Contraceptive Sales Forecast by Product 2018-2025 (K Units)
Table Global Intrauterine Contraceptive Sales Market Share Forecast by Product 2018-2025
Table Global Intrauterine Contraceptive Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Intrauterine Contraceptive Revenue Market Share Forecast by Product 2018-2025
Table Global Intrauterine Contraceptive Sales Forecast by End User 2018-2025 (K Units)
Table Global Intrauterine Contraceptive Sales Market Share Forecast by End User 2018-2025
Figure North America Intrauterine Contraceptive Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Intrauterine Contraceptive Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Intrauterine Contraceptive Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Intrauterine Contraceptive Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Intrauterine Contraceptive Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Intrauterine Contraceptive Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Intrauterine Contraceptive Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Intrauterine Contraceptive Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Intrauterine Contraceptive Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Intrauterine Contraceptive Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Intrauterine Contraceptive Value Chain
Table Intrauterine Contraceptive Customers List
Table Intrauterine Contraceptive Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
